Newest first. 5.2k questions across 107 tags.
Timing, since it always gets asked: this started nine days after a dose step. I want to understand what this actually establishes, as opposed to what it is being used…
For reference: a 1 mL luer-lock syringe · 20 mg · 20 mg/mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers…
I have three scans from the same centre, same technician, morning fasted each time, and I want a sanity check on how to read them, because the second scan made me cut…
Details up front: AST · ecnoglutide. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to reason…
Setup, so nobody has to ask: STEP 5 · semaglutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
What I am working with: dimerisation · a GLP-1 receptor agonist · PeptideMeter. This is a procedural question rather than a theoretical one, and I would like the…
What I am working with: PIONEER-1 · oral semaglutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The particulars: QSC · SWB · the Netherlands. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints…
Scale weight, waist circumference and a repetition maximum, all logged weekly. I would like help reading this properly rather than being told what conclusion to…
Details up front: an 18G drawing needle · orforglipron · 8 mg/mL. I have used one of these for a while and I am considering switching, which requires a reason. What I…
This is my second independent submission on material from the same supplier. I would rather over-plan the first cycle and simplify later. I am prepared to do the work…
Details up front: a U-100 insulin syringe · 2.5 mg · 2.5 mg/mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to…
Details up front: hydrolysis · dulaglutide · 4 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
Numbers first: cagrilintide · minus 80 °C. I would like to understand the steps well enough to explain them to someone else. I have access to a refrigerator with a…
What I have: a GLP-1 receptor agonist · sixteen weeks · 40 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a…
The case in front of me: 20 units · 5 mg/mL. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one mistake…
The specifics, since they change the answer: Nantong · Australia. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
Stated plainly: HJ · MKM · the United Kingdom. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so…
The specifics, since they change the answer: SURMOUNT-5 · headache · 5 mg. I have the document in front of me and I can read the numbers. What I cannot do is…
I have kept every message, invoice and document, which I gather is the useful habit. I am at the decision point and I would rather think it through than improvise. I…
What I have: Zhuhai · New Zealand. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable with…
Stated plainly: aggregation · a GLP-1 receptor agonist · PeptideMeter. Everything I have found on this is either a forum aside or a product page, neither of which I…
Setup, so nobody has to ask: BCH · KP · New Zealand. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
Stated plainly: an on-chain payment · the United States. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…